{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:05:57Z","timestamp":1794056757955,"version":"4.8.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ygyno.2023.06.015","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T05:37:08Z","timestamp":1687844228000},"page":"142-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer"],"prefix":"10.1016","volume":"175","author":[{"given":"Molly","family":"Morton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sciuva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Perni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0005","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.ejcn.1602540","article-title":"Malnutrition among gynaecological cancer patients","volume":"61","author":"Laky","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.ygyno.2023.06.015_bb0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s12603-022-1826-4","article-title":"Increased emergency department utilization and costs for Medicare cancer patients with malnutrition diagnoses","volume":"26","author":"Sulo","year":"2022","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.ygyno.2023.06.015_bb0015","first-page":"10","article-title":"Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study","author":"Laky","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0020","first-page":"844","article-title":"Prognostic nutritional index in relation to hospital stay in women with gynecologic cancer","volume":"95","author":"Santoso","year":"2000","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.ygyno.2023.06.015_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41430-022-01180-9","article-title":"Nutritional status assessed by patient-generated subjective global assessment is associated with toxicity to chemoradiotherapy in women with cervical cancer: a prospective study","volume":"76","author":"Mota","year":"2022","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejso.2021.10.015","article-title":"Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications","volume":"48","author":"van der Zanden","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2022.01.030","article-title":"Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: analysis using a national surgical outcomes database","volume":"165","author":"Goins","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/IGC.0000000000000867","article-title":"Sarcopenia in advanced serous ovarian cancer","volume":"27","author":"Bronger","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2016.05.027","article-title":"Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer","volume":"142","author":"Kumar","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.06.015_bb0050","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/ijgc-2022-003387","article-title":"Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer","volume":"32","author":"Polen-De","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/a-1608-1309","article-title":"The pretreatment controlling nutritional status score in ovarian cancer: influence on prognosis, surgical outcome, and postoperative complication rate","volume":"82","author":"Bekos","year":"2022","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.015_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113184","article-title":"Effect of muscle loss but not fat loss during primary Debulking surgery and chemotherapy on prognosis of patients with ovarian cancer","volume":"11","author":"Nakayama","year":"2022","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0065","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/ijgc-2020-001215","article-title":"Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis","volume":"30","author":"Rinninella","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1245\/s10434-014-4040-8","article-title":"Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer","volume":"22","author":"Kuroki","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/01635581.2021.1910320","article-title":"Malnutrition and the survival of cervical cancer patients: a prospective cohort study using the PG-SGA tool","volume":"74","author":"Argefa","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273876","article-title":"Hypoalbuminemia for the prediction of survival in patients with stage IVB cervical cancer","volume":"17","author":"Yoshikawa","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejogrb.2013.07.044","article-title":"The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer","volume":"171","author":"Seebacher","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00404-021-06273-7","article-title":"The impact of nutritional risk factors and sarcopenia on survival in patients treated with pelvic exenteration for recurrent gynaecological malignancy: a retrospective cohort study","volume":"305","author":"Seebacher","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0095","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7861\/clinmedicine.10-6-624","article-title":"Malnutrition: causes and consequences","volume":"10","author":"Saunders","year":"2010","journal-title":"Clin. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2023.06.015_bb0100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.ejcn.1601412","article-title":"Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer","volume":"56","author":"Bauer","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jpen.1440","article-title":"GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community","volume":"43","author":"Jensen","year":"2019","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.015_bb0110","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/ijgc-2020-001678","article-title":"A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy","volume":"30","author":"Allanson","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"23","key":"10.1016\/j.ygyno.2023.06.015_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10235552","article-title":"Sarcopenia: diagnosis and management, state of the art and contribution of ultrasound","volume":"10","author":"Giovannini","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0125","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e31827a0f27","article-title":"Objective radiological assessment of body composition in patients with end-stage liver disease: going beyond the BMI","volume":"95","author":"Cruz","year":"2013","journal-title":"Transplantation."},{"issue":"8","key":"10.1016\/j.ygyno.2023.06.015_bb0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0140","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0150","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.3389\/fonc.2021.741071","article-title":"Impact of computed tomography-based, artificial intelligence-driven volumetric sarcopenia on survival outcomes in early cervical cancer","volume":"11","author":"Han","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ijgo.13591","article-title":"The role of sarcopenic obesity in high-grade endometrial cancer","volume":"154","author":"Donkers","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.clnu.2012.06.010","article-title":"Sarcopenic obesity: a critical appraisal of the current evidence","volume":"31","author":"Prado","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0170","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.2147\/CMAR.S261585","article-title":"Cancer cachexia: definition, staging, and emerging treatments","volume":"12","author":"Ni","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0175","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41430-018-0245-4","article-title":"Cancer-associated malnutrition","volume":"72","author":"Baracos","year":"2018","journal-title":"Eur. J. Clin. Nutr."},{"issue":"36","key":"10.1016\/j.ygyno.2023.06.015_bb0180","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.21.01900","article-title":"Modification of the association between frequent aspirin use and ovarian cancer risk: a meta-analysis using individual-level data from two ovarian cancer consortia","volume":"40","author":"Hurwitz","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0185","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1042\/BCJ20201009","article-title":"Cancer cachexia: molecular mechanism and pharmacological management","volume":"478","author":"Li","year":"2021","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support Palliat Care"},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-induced skeletal muscle dysfunction: mechanisms and counteracting therapeutic strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0205","first-page":"2","article-title":"Cancer cachexia","author":"Martignoni","year":"2003","journal-title":"Mol. Cancer"},{"issue":"5547","key":"10.1016\/j.ygyno.2023.06.015_bb0210","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCO.0000000000000048","article-title":"Coming back: autophagy in cachexia","volume":"17","author":"Penna","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188359","article-title":"Advances in cancer cachexia: intersection between affected organs, mediators, and pharmacological interventions","volume":"1873","author":"Siddiqui","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0230","first-page":"1","article-title":"Mitochondrial impairment in sarcopenia","volume":"10","author":"Bellanti","year":"2021","journal-title":"Biology (Basel)"},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.015_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113150","article-title":"Mitochondrial dysfunction in cancer cachexia: impact on muscle health and regeneration","volume":"10","author":"Beltr\u00e0","year":"2021","journal-title":"Cells."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0240","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.26811","article-title":"Adipose tissue dysfunction in cancer cachexia","volume":"234","author":"Daas","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jcsm.12059","article-title":"Pathophysiology of anorexia in the cancer cachexia syndrome","volume":"6","author":"Ezeoke","year":"2015","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0255","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/jcsm.13037","article-title":"Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya sarcopenia study","volume":"13","author":"Wang","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.015_bb0260","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/jir.2013.0020","article-title":"The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer","volume":"34","author":"Jiang","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"issue":"2 Suppl","key":"10.1016\/j.ygyno.2023.06.015_bb0265","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajcn\/47.2.357","article-title":"A randomized clinical trial of total parenteral nutrition in malnourished surgical patients: the rationale and impact of previous clinical trials and pilot study on protocol design","volume":"47","author":"Buzby","year":"1988","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0270","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/nu14122392","article-title":"Malnutrition screening and assessment","volume":"14","author":"Ser\u00f3n-Arbeloa","year":"2022","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0275","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12885-020-07052-4","article-title":"Nutritional status according to the mini nutritional assessment (MNA)\u00ae as potential prognostic factor for health and treatment outcomes in patients with cancer \u2013 a systematic review","volume":"20","author":"Torbahn","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2023.06.015_bb0280","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0285","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/gerona\/glt073","article-title":"Functional status and mortality in older women with gynecological cancer","volume":"68","author":"Cesari","year":"2013","journal-title":"J. Gerontol. Ser. A"},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0290","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.21873\/invivo.12595","article-title":"Screening tools for sarcopenia","volume":"35","author":"Nishikawa","year":"2021","journal-title":"In Vivo (Brooklyn)"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010010","article-title":"Prognostic impact of the SARC-F score in gastrointestinal advanced cancers","volume":"14","author":"Matsui","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jjco\/hyaa218","article-title":"Validity of measuring psoas muscle mass index for assessing sarcopenia in patients with gynecological cancer","volume":"51","author":"Yamada","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2023.06.015_bb0305","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1002\/cam4.4354","article-title":"Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer","volume":"10","author":"Park","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08537-6","article-title":"Exploring the malnutrition status and impact of total parenteral nutrition on the outcome of patients with advanced stage ovarian cancer","volume":"21","author":"Yan","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2023.06.015_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2014.03.045","article-title":"Nutritional risk index as a significant prognostic factor in advanced-stage epithelial ovarian cancer patients","volume":"133","author":"Yoon","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0320","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3389\/fonc.2019.01562","article-title":"The value of prognostic nutritional index (PNI) in predicting survival and guiding radiotherapy of patients with T1-2N1 breast cancer","volume":"9","author":"Hua","year":"2020","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0325","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3945\/ajcn.112.037853","article-title":"Malnutrition self-screening by using MUST in hospital outpatients: validity, reliability, and ease of use","volume":"96","author":"Cawood","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/nu9030287","article-title":"Analysis of outcomes of the NRS 2002 in patients hospitalized in nephrology wards","volume":"9","author":"Borek","year":"2017","journal-title":"Nutrients."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0335","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ajg.2016.28","article-title":"ACG clinical guideline: nutrition therapy in the adult hospitalized patient","volume":"111","author":"McClave","year":"2016","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.015_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132857","article-title":"Nutritional risk screening 2002 as a predictor of postoperative outcomes in patients undergoing abdominal surgery: a systematic review and meta-analysis of prospective cohort studies","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0345","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.clnu.2021.02.032","article-title":"Nutritional risk is a predictor for long-term mortality: 5-year follow-up of the EFFORT trial","volume":"40","author":"Efthymiou","year":"2021","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0350","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/2278-330X.126518","article-title":"Assessment of nutritional status of gynecological cancer cases in India and comparison of subjective and objective nutrition assessment parameters","volume":"3","author":"Das","year":"2014","journal-title":"South Asian J. Cancer"},{"issue":"13","key":"10.1016\/j.ygyno.2023.06.015_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/nu14132642","article-title":"Dietary supplements in people with metastatic cancer who are experiencing malnutrition, cachexia, sarcopenia, and frailty: a scoping review","volume":"14","author":"Johal","year":"2022","journal-title":"Nutrients."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MCO.0000000000000389","article-title":"Assessing nutritional status in cancer: role of the patient-generated subjective global assessment","volume":"20","author":"Jager-Wittenaar","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab Care"},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0365","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1016\/j.jada.2008.06.372","article-title":"Screening for malnutrition risk in cancer outpatients using an abridged PG-SGA","volume":"108","author":"Robinson","year":"2008","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0370","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcrc.2017.12.027","article-title":"Early nutritional inadequacy is associated with psoas muscle deterioration and worse clinical outcomes in critically ill surgical patients","volume":"45","author":"Yeh","year":"2018","journal-title":"J. Crit. Care"},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061980","article-title":"The Spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review","volume":"13","author":"Bossi","year":"2021","journal-title":"Nutrients."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0380","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s12032-011-0019-5","article-title":"Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer","volume":"29","author":"Asher","year":"2012","journal-title":"Med. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.015_bb0385","first-page":"3673","article-title":"Inflammatory and nutritional serum markers as predictors of Peri-operative morbidity and survival in ovarian cancer","volume":"37","author":"Kumar","year":"2017","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188639","article-title":"The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients","volume":"1876","author":"Szulc-Kielbik","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0395","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.clnu.2022.07.007","article-title":"Association of Global Leadership Initiative on malnutrition with survival outcomes in patients with cancer: a systematic review and meta-analysis","volume":"41","author":"Xu","year":"2022","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64171-5","article-title":"The preoperative prognostic nutritional index for the prediction of outcomes in patients with early-stage ovarian clear cell carcinoma","volume":"10","author":"Yoshikawa","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0405","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08537-6","article-title":"Exploring the malnutrition status and impact of total parenteral nutrition on the outcome of patients with advanced stage ovarian cancer","volume":"21","author":"Yan","year":"2021","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2023.06.015_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272232","article-title":"Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: a prospective database analysis","volume":"17","author":"Njoku","year":"2022","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.ygyno.2023.06.015_bb0415","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1158\/1078-0432.CCR-18-0788","article-title":"Skeletal muscle loss is an imaging biomarker of outcome after definitive chemoradiotherapy for locally advanced cervical cancer","volume":"24","author":"Lee","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0420","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10147-022-02140-w","article-title":"Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy","volume":"27","author":"Abe","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0425","first-page":"8","article-title":"Progressive skeletal muscle loss after surgery and adjuvant radiotherapy impact survival outcomes in patients with early stage cervical cancer","author":"Lee","year":"2022","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0029665120007855","article-title":"Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice","volume":"80","author":"Ryan","year":"2021","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0435","first-page":"67","article-title":"Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival","author":"Ryan","year":"2019","journal-title":"Nutrition."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0440","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/IGC.0000000000001157","article-title":"Sarcopenia and skeletal muscle quality as predictors of postoperative complication and early mortality in gynecologic cancer","volume":"28","author":"Silva De Paula","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0445","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2021.05.039","article-title":"Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer","volume":"162","author":"van der Zanden","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0450","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2022.11.024","article-title":"Association between CT-based body composition assessment and patient outcomes during neoadjuvant chemotherapy for epithelial ovarian cancer","volume":"169","author":"Wood","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0455","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ygyno.2020.01.003","article-title":"Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy","volume":"156","author":"Staley","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0460","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ygyno.2020.09.042","article-title":"No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study","volume":"159","author":"Ubachs","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0465","first-page":"8","article-title":"The effect of nutrition intervention with Oral nutritional supplements on ovarian cancer patients undergoing chemotherapy","author":"Qin","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0470","first-page":"12","article-title":"Nutritional support during the hospital stay is cost-effective for preventing adverse outcomes in patients with cancer","author":"Schuetz","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0475","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ygyno.2022.10.013","article-title":"Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction","volume":"167","author":"Peters","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0480","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/gyno.1996.4605","article-title":"Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction","volume":"64","author":"Abu-Rustum","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.06.015_bb0485","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.clnu.2022.07.039","article-title":"Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: a systematic review of randomised controlled trials","volume":"41","author":"Miller","year":"2022","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0490","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e77","article-title":"Immunonutrition in ovarian cancer: clinical and immunological impact?","volume":"33","author":"Ferrero","year":"2022","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020437","article-title":"Paving the path for immune enhancing nutrition in colon cancer: modulation of tumor microenvironment and optimization of outcomes and costs","volume":"15","author":"Ambrosio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0500","first-page":"1277","article-title":"Perceptions of oncology providers and cancer survivors on the role of nutrition in cancer care and their views on the \u201cNutriCare\u201d program","volume":"12","author":"Keaver","year":"2023","journal-title":"Nutr"},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.015_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062498","article-title":"BREAst cancer personalised NuTrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy - a protocol for a randomised clinical trial","volume":"12","author":"Rein","year":"2022","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.ygyno.2023.06.015_bb0510","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36898","article-title":"Association of National expansion of insurance coverage of medically tailored meals with estimated hospitalizations and health care expenditures in the US","volume":"5","author":"Hager","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0515","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamainternmed.2019.0198","article-title":"Association between receipt of a medically tailored meal program and health care use","volume":"179","author":"Berkowitz","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"22","key":"10.1016\/j.ygyno.2023.06.015_bb0520","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.00687","article-title":"Exercise, diet, and weight management during cancer treatment: ASCO guideline","volume":"40","author":"Ligibel","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0525","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2020.09.008","article-title":"Water only fasting and its effect on chemotherapy administration in gynecologic malignancies","volume":"159","author":"Riedinger","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0530","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1615\/CritRevOncog.v17.i3.60","article-title":"Therapeutic exercise in cancer cachexia","volume":"17","author":"Maddocks","year":"2012","journal-title":"Crit. Rev. Oncog."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0535","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise: molecular mechanisms","volume":"4","author":"Gould","year":"2012","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0540","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cphy.c120005","article-title":"Cancer, physical activity, and exercise","volume":"2","author":"Brown","year":"2012","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0545","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/epirev\/mxx007","article-title":"The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects","volume":"39","author":"Cormie","year":"2017","journal-title":"Epidemiol. Rev."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0550","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-016-3900-2","article-title":"Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial","volume":"158","author":"Adams","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.015_bb0555","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1055-9965.EPI-15-1330","article-title":"Chronic recreational physical inactivity and epithelial ovarian cancer risk: evidence from the ovarian cancer association consortium","volume":"25","author":"Cannioto","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0560","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bjc.2016.153","article-title":"Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the ovarian cancer association consortium","volume":"115","author":"Cannioto","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2023.06.015_bb0565","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1136\/ijgc-2020-001543","article-title":"Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study","volume":"30","author":"Fleming","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2023.06.015_bb0570","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.physio.2016.02.006","article-title":"Exercise interventions for patients with gynaecological cancer: a systematic review and meta-analysis","volume":"102","author":"Lin","year":"2016","journal-title":"Physiotherapy."},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0575","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ygyno.2020.06.485","article-title":"Physical activity and exercise in women with ovarian cancer: a systematic review","volume":"158","author":"Jones","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0580","series-title":"Supervised Resistance Exercise for Women with Ovarian Cancer Who Have Completed First-Line Treatment: A Pragmatic Study","first-page":"304","volume":"31","author":"Schofield","year":"2023"},{"key":"10.1016\/j.ygyno.2023.06.015_bb0585","author":"Prehabilitation"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0590","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-022-12623-9","article-title":"Improved postoperative outcomes after Prehabilitation for colorectal cancer surgery in older patients: an emulated target trial","volume":"30","author":"Heil","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0595","article-title":"A multimodal prehabilitation program for the reduction of post-operative complications after surgery in advanced ovarian cancer under an ERAS pathway: a randomized multicenter trial (SOPHIE)","author":"D\u00edaz-Feijoo","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2023.06.015_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071635","article-title":"Feasibility of a multimodal Prehabilitation programme in patients undergoing Cytoreductive surgery for advanced ovarian cancer: a pilot study","volume":"14","author":"Diaz-Feijoo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ygyno.2023.06.015_bb0605","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-022-02517-1","article-title":"Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study","volume":"20","author":"Miralpeix","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0610","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e92","article-title":"Prehabilitation for medically frail patients undergoing surgery for epithelial ovarian cancer: a cost-effectiveness analysis","volume":"32","author":"Dholakia","year":"2021","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0615","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1159\/000492559","article-title":"Ghrelin as a promising therapeutic option for cancer cachexia","volume":"48","author":"Khatib","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2017.07.023","article-title":"Anamorelin for advanced non-small-cell lung cancer with cachexia: systematic review and meta-analysis","volume":"112","author":"Nishie","year":"2017","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2023.06.015_bb0625","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"2013","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0630","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1049909109345685","article-title":"Phase II trial of mirtazapine for cancer-related cachexia and anorexia","volume":"27","author":"Riechelmann","year":"2010","journal-title":"Am. J. Hosp. Palliat Care"},{"issue":"6","key":"10.1016\/j.ygyno.2023.06.015_bb0635","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jpainsymman.2021.05.017","article-title":"Mirtazapine in cancer-associated anorexia and cachexia: a double-blind placebo-controlled randomized trial","volume":"62","author":"Hunter","year":"2021","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2023.06.015_bb0640","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.01997","article-title":"Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer","author":"Sandhya","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"S2","key":"10.1016\/j.ygyno.2023.06.015_bb0645","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/jpen.2287","article-title":"Nutrition challenges of cancer cachexia","volume":"45","author":"Gaafer","year":"2021","journal-title":"J. Parenter. Enter. Nutr."},{"issue":"29","key":"10.1016\/j.ygyno.2023.06.015_bb0650","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1200\/JCO.2013.54.3926","article-title":"Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial","volume":"32","author":"Paulsen","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2023.06.015_bb0655","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: clinical nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"issue":"21","key":"10.1016\/j.ygyno.2023.06.015_bb0660","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"Strasser","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"58","key":"10.1016\/j.ygyno.2023.06.015_bb0665","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jncimonographs\/lgab011","article-title":"The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids","volume":"2021","author":"Sexton","year":"2021","journal-title":"J. Natl. Cancer Inst. Monogr."},{"issue":"9","key":"10.1016\/j.ygyno.2023.06.015_bb0670","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1007\/s00520-022-07170-8","article-title":"In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center","volume":"30","author":"Raghunathan","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ygyno.2023.06.015_bb0675","first-page":"37","article-title":"Medical marijuana utilization in gynecologic cancer patients","author":"Fehniger","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2023.06.015_bb0680","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a north central cancer treatment group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582300358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582300358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T20:54:25Z","timestamp":1715806465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582300358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":136,"alternative-id":["S009082582300358X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.015","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}